EssilorLuxottica (EL) issues new shares for dividend payments after AGM decision
EssilorLuxottica, the Franco-Italian eyewear conglomerate, has announced the issuance of 957,954 new shares designated for dividend payments. This initiative, which represents 0.21% of the company's total share capital, stems from a decision made at the annual general meeting to provide shareholders with the option of receiving their dividends in company stock.
The price for these newly issued shares has been fixed at €175.06 per unit. The settlement, delivery, and subsequent admission of these shares to trading on Euronext Paris are scheduled for 3 June 2026. This method of dividend distribution is a frequently employed mechanism by publicly traded entities, enabling companies to conserve cash reserves and maintain liquidity while still fulfilling their commitment to shareholder remuneration.
On 1 June 2026, EssilorLuxottica shares are trading at €171.55, marking a 2.1% decline from their previous close of €175.15. The market's response to the announcement has been moderate. While the issuance of new shares inherently introduces a slight dilution to the existing capital base, this effect appears to be largely offset by the provision of an alternative and flexible remuneration option for investors.
How a Stock Dividend Alters EssilorLuxottica's Capital Value
EssilorLuxottica is a global leader in eyewear, designing, manufacturing, and distributing prescription lenses, spectacle frames, and sunglasses. The company boasts a portfolio of well-known brands, serving a vast international market of consumers who need vision correction and stylish eyewear. Its revenue primarily comes from the sale of these products, from prescription to retail distribution.
The recent announcement from EssilorLuxica details the issuance of 957,954 new shares, representing 0.21% of its share capital, specifically for dividend payments. This move allows the French firm to reward its shareholders by offering them new stock instead of cash, thus preserving its treasury. While the total capital of the company remains unchanged, increasing the number of shares in circulation means that each existing share now represents a slightly smaller proportion of the overall ownership, which can also impact future earnings per share. The new shares were priced at €175.06.
This slight dilution of existing ownership explains the moderate market reaction. EssilorLuxottica is currently trading at €171.55, a 2.1% decline from its previous close of €175.15.
Imagine you own a specific percentage of a successful, privately held business. If the owners decide to issue new shares to pay out profits, rather than distributing cash, your original stake doesn't suddenly become less valuable in absolute terms, but your percentage ownership of the company slightly decreases because more shares now exist. The business itself hasn't grown, but your slice of the pie has become marginally smaller.
EssilorLuxottica
EssilorLuxottica S.A. (EL) is a global leader in ophthalmic products, specialising in the design, manufacture, and distribution of lenses, frames, and sunglasses. Its operations span North America, Europe, Latin America, Asia, Oceania, and Africa, organised across five key segments: Wholesale, Retail, Lenses and Optical Instruments, Equipment, and Sunglasses and Readers. The company's diverse portfolio includes well-known lens brands such as Varilux, Crizal, and Transitions, alongside optical instruments for professionals. Its Equipment division supplies digital surfacing and lens coating machines. The Sunglasses and Readers segment offers a wide array of non-prescription eyewear under various brands, including Foster Grant and Bolon. With a network of 490 prescription laboratories and edging-mounting facilities, EssilorLuxottica was founded in 1849 and is headquartered in Paris, France.